For the first time in India, Hester Biosciences Limited has launched a poultry vaccine against Coryza disease in chicken, containing three serotypes namely A, B and C. So far, companies have manufactured vaccine with only A and C strains.
Coryza disease is of economica importance to poultry farmers as it causes a drop in egg production in laying birds. Currently, the market for Coryza vaccine is approximately Rs 80 million and 50 per cent of the vaccine demand in the country is fulfilled through imports.
Offering an import substitute for the vaccine, Hester strives to penetrate into the market. Currently, the company manufactures 39 types of poultry vaccines against various poultry diseases.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app